Overview
7 featuresHead Pain Journal‑App sits in PulseGate's Health & fitness category. It enables migraine sufferers to easily log and track headache episodes and related health data for better management and doctor reporting. It is built as a consumer product for individuals with migraines or chronic headaches. A free plan is available. Head Pain Journal‑App is available on iOS.
It is developed by Chris Thrasher (United States), and it first shipped in 2026. Key capabilities include migraine tracking, one-tap logging, and cycle tracking.
- ✓Migraine tracking
- ✓One-tap logging
- ✓Cycle tracking
- ✓PDF export
- ✓Apple Health integration
- ✓Custom triggers
- ✓Low light themes
Tagsmigraine-trackerheadache-logcycle-correlationhealth-journal
Built with & integrations
Trust & compliance
Verified signals✓HTTPS✓Free tier✓Store-verified publisher
Indexing history
1What PulseGate has recorded for this listing
Indexed6 Jul · 17:46 UTC
Head Pain Journal verified against its public source
Frequently asked questions about Head Pain Journal‑App
- What is Head Pain Journal‑App?
- Head Pain Journal‑App enables migraine sufferers to easily log and track headache episodes and related health data for better management and doctor reporting. It is catalogued under Health & fitness on PulseGate.
- Who should use Head Pain Journal‑App?
- Head Pain Journal‑App is a consumer product built for individuals with migraines or chronic headaches.
- Is Head Pain Journal‑App free?
- Yes — there is a free tier, with paid plans for advanced use.
- What platforms does Head Pain Journal‑App run on?
- Head Pain Journal‑App runs on iOS.
- Is Head Pain Journal‑App still maintained?
- Unverified. Head Pain Journal‑App has not been re-checked since it entered the index, so there is no finding either way — and only a positive finding would say otherwise.
- Who makes Head Pain Journal‑App?
- Head Pain Journal‑App is developed by Chris Thrasher, based in the United States.
- How long has Head Pain Journal‑App been around?
- Head Pain Journal‑App first shipped in 2026.